NO20005217D0 - DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav - Google Patents

DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav

Info

Publication number
NO20005217D0
NO20005217D0 NO20005217A NO20005217A NO20005217D0 NO 20005217 D0 NO20005217 D0 NO 20005217D0 NO 20005217 A NO20005217 A NO 20005217A NO 20005217 A NO20005217 A NO 20005217A NO 20005217 D0 NO20005217 D0 NO 20005217D0
Authority
NO
Norway
Prior art keywords
structural protein
dna encoding
infectious salmon
anemia virus
protein
Prior art date
Application number
NO20005217A
Other languages
English (en)
Other versions
NO330866B1 (no
NO20005217L (no
Inventor
Eirik E Biering
Bjoern B Krossoey
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005217(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20005217D0 publication Critical patent/NO20005217D0/no
Publication of NO20005217L publication Critical patent/NO20005217L/no
Publication of NO330866B1 publication Critical patent/NO330866B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • C07K16/108Orthomyxoviridae (F), e.g. influenza virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005217A 1999-10-18 2000-10-17 Peptid, vaksine, diagnostisk sett samt anvendelse av en nukleotidsekvens NO330866B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203401 1999-10-18

Publications (3)

Publication Number Publication Date
NO20005217D0 true NO20005217D0 (no) 2000-10-17
NO20005217L NO20005217L (no) 2001-04-19
NO330866B1 NO330866B1 (no) 2011-08-01

Family

ID=8240749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005217A NO330866B1 (no) 1999-10-18 2000-10-17 Peptid, vaksine, diagnostisk sett samt anvendelse av en nukleotidsekvens

Country Status (10)

Country Link
US (1) US6471964B1 (no)
EP (1) EP1094069B2 (no)
JP (1) JP4777508B2 (no)
AT (1) ATE286507T1 (no)
AU (1) AU778791B2 (no)
CA (1) CA2321437A1 (no)
DE (1) DE60017229D1 (no)
DK (1) DK1094069T4 (no)
NO (1) NO330866B1 (no)
NZ (1) NZ507530A (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637614A3 (en) 1999-08-07 2006-11-29 Novartis AG Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus)
WO2001066569A1 (en) * 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
US20030108901A1 (en) * 2001-07-17 2003-06-12 Kibenge Frederick S.B. Serological test for ISAV in fish
DE60239753D1 (de) 2001-10-19 2011-05-26 Intervet Int Bv Impfstoff gegen infektiöses lachsanämievirus
US7317142B2 (en) 2002-12-13 2008-01-08 Prodi Gene, Inc. Immunization of fish with plant-expressed recombinant proteins
CA2687208C (en) 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1200110A (zh) * 1995-10-18 1998-11-25 拜尔公司 亚氨基乙酰胺类化合物
DE69736163T2 (de) * 1996-11-04 2007-05-03 Ottawa Health Research Institute, Ottawa Verfahren zur Expression von Polypeptide in Fischen durch eintauchen in eine plasmid DNA enthaltende Lösung
JP2002536958A (ja) * 1997-11-21 2002-11-05 ジェンセット Chlamydiapneumoniaeゲノム配列およびポリペプチド、それらのフラグメント、ならびに特に感染症の診断、予防および治療のためのそれらの使用
EP1637614A3 (en) * 1999-08-07 2006-11-29 Novartis AG Nucleic acids and antibodies for detection of ISAV (infectious salmon anaemia virus)

Also Published As

Publication number Publication date
EP1094069B2 (en) 2008-04-23
ATE286507T1 (de) 2005-01-15
JP4777508B2 (ja) 2011-09-21
AU6653800A (en) 2001-04-26
DE60017229D1 (de) 2005-02-10
US6471964B1 (en) 2002-10-29
NZ507530A (en) 2001-08-31
EP1094069A1 (en) 2001-04-25
NO330866B1 (no) 2011-08-01
JP2001211888A (ja) 2001-08-07
CA2321437A1 (en) 2001-04-18
AU778791B2 (en) 2004-12-23
EP1094069B1 (en) 2005-01-05
DK1094069T3 (da) 2005-05-17
DK1094069T4 (da) 2008-07-21
NO20005217L (no) 2001-04-19

Similar Documents

Publication Publication Date Title
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
DE69535061D1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
CY1106513T1 (el) Λεντινοϊικο τριπλο dna και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dna
DE60120621D1 (de) Lawsonia intracellularis Impfstoff
NO20005217L (no) DNA som koder for strukturelt protein-1 i infeksiös lakseanemivirus og anvendelse derav
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
NO885090D0 (no) Polypeptider.
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
NO20041564L (no) Infeksios lakse anemi-virus vaksine
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
ES2095258T3 (es) Nuevo virus de la enfermedad de la bolsa infecciosa.
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees